Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
AstraZeneca
Express Scripts
Merck
Mallinckrodt

Last Updated: December 5, 2022

PTAB Cases from ACTAVIS, INC.


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Patent Trial and Appeal Board Cases for Petitioner: ACTAVIS, INC.

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
RE38,551 ACTAVIS, INC. See Plans and Pricing 2014-07-10 07-10-2014 Research Corporation Technologies, Inc. Inter partes review See Plans and Pricing 01-09-2015 Harold Kohn See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Baxter
Harvard Business School
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.